Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)

NCT04245748 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT04245748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04245748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
Lead sponsor
University of Cincinnati
Phase
Phase 4
Overall status
Recruiting
Start date
March 1, 2020
Completion date
December 31, 2025
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxious depression, depression